Inglenook Vineyards Teams Up With Colony Liquor & Wine
to Fund Breast Cancer Research Through American Cancer Society

CONCORD, Calif., Sept. 25, 2002 – Inglenook Vineyards is teaming up with upstate New York distributor Colony Liquor & Wine to support National Breast Cancer Awareness Month in October.  Inglenook and Colony plan to donate a portion of their October sales – up to a combined total of $5,000 – to the Southern New York and Central New York Regional chapters of the American Cancer Society to fund breast cancer research.

“The American Cancer Society is truly dedicated to making a difference in this community, and Inglenook is proud to partner with them to help find a cure for breast cancer,” said Diana Pawlik, brand manager for Inglenook.  “Our commitment is driven by our desire to give back to the communities we do business in.  We hope local residents will join us in this important effort.”

In this, the second year of Inglenook’s national campaign to raise money for breast cancer research, New York state retailers will be participating in the Breast Cancer Awareness program through special in-store displays.  Consumers interested in supporting the effort can purchase Inglenook wines during the month of October.  A portion of the proceeds from each bottle of wine sold in upstate New York will be donated to the local offices of the American Cancer Society for breast cancer research. 

“Tamoxifen, Herceptin, and the breast cancer gene are all research advances that began with communities around the country supporting the American Cancer Society,” said Lisa Smith, American Cancer Society’s Regional Vice President of Central New York.  “The commitment by organizations like Inglenook Vineyards and Colony Liquor & Wine to fight breast cancer enables us to fund research that will help us unravel the mystery of how breast cancer begins, and seek better ways to prevent, detect and treat this disease.”

Inglenook Vineyards will also be participating in breast cancer awareness events across the country throughout the month of October, and will donate a portion of the month’s national sales to the American Association for Cancer Research (AACR).  These funds, called the Inglenook Awards, will be used to enhance the education of up to 20 top early-career scientists in the field.  The AACR is the world’s oldest scientific organization dedicated to preventing and curing cancer. 

Recent studies show that breast cancer is the leading form of cancer in women, and one in eight women will develop the disease during her lifetime.  With its large number of consumers, Inglenook – a Canandaigua Wine Company brand that sells nearly 5 million cases of wine each year – hopes to raise public awareness of the disease and support a cure.

Inglenooks wines are made by Canandaigua Wine Company, a division of Constellation Brands, Inc. (NYSE: STZ, STZ.B). Canandaigua Wine, the world's second largest wine company, satisfies millions of consumers nationwide by providing quality wines for the enjoyment of everyday life. Canandaigua Wine produces, markets and sells more than 40 well-known brands. Leading table wine brands include Alice White, Almaden, Columbia, Covey Run, Dunnewood, Inglenook, Talus and Vendange. Constellation Brands, Inc. is a leading producer and marketer of beverage alcohol brands, with a broad portfolio of wines, spirits and imported beers. The Company is the largest single-source provider of these products in the United States, and both a major producer and independent drinks wholesaler in the United Kingdom.

FOR FURTHER INFORMATION CONTACT: Balzac Communications, Margaret Clark (707) 255-8023.